In this resource library we share documents, presentations, forms, videos and useful links from Pinnacle and the wider sector.
Use the search box and filters to help find what you're looking for or view all COVID-19 resources
Can't find what you need? Try searching in programmes.
Jo Scott-Jones and Dave Maplesden discuss diverticulitis, new free resources available through Healthpathways, a financial benefits WINZ resource, and more.
From 30 September 2024, the following insulins will no longer be available in Aotearoa New Zealand: Penmix30, Penmix50 and Mixtard30. NZSSD has issued recommendations for switching to alternative insulins.
A guide for clinical management of type 2 diabetes, including information from a variety of sources. The guide is intended to support nurses at all levels to develop their knowledge and clinical reasoning in diabetes care.
Waikato hepatitis protocol for management of pregnant woman, household contacts and babies born to HBsAg mothers.
A guide for clinical management of type 2 diabetes, including information from a variety of sources. The guide is intended to support nurses at all levels to develop their knowledge and clinical reasoning in diabetes care.
The Aotearoa Diabetes Collective has created a useful guide with templates for letters to support applications for CGM and empagliflozin (for those already prescribed a GLP1ra) for people living with type 2 diabetes.
Pinnacle delivers a number of reports into practice Healthlink folders (Medtech) or PHO folders (indici). Guides have been developed for some of these to help you locate the report in your Healthlink / PHO folder and to ensure the correct person in your practice receives it.
Jo Scott-Jones and Dave Maplesden discuss Heart Foundation resources, Atrial fibrillation and anticoagulation, Pharmac supply updates, and more.
Pneumonia is a significant cause of mortality in children and older people, particularly among Māori and Pacific peoples. Prompt identification and treatment will enable patients with initially less severe community-acquired pneumonia to be managed at home, reducing hospitalisation and mortality.
Dr Tony Muller, psychiatrist, is able to review special authority (SA) requests for methylphenidate and dexamfetamine, and apply for them if the information supplied confirms the appropriateness of continued treatment. In the majority of cases Dr Muller can action these without needing a psychiatric assessment.